These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17085491

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
    Bossart-Whitaker P, Carson M, Babu YS, Smith CD, Laver WG, Air GM.
    J Mol Biol; 1993 Aug 20; 232(4):1069-83. PubMed ID: 8371267
    [Abstract] [Full Text] [Related]

  • 63. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Hurt AC, Selleck P, Komadina N, Shaw R, Brown L, Barr IG.
    Antiviral Res; 2007 Mar 20; 73(3):228-31. PubMed ID: 17112602
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
    Puzelli S, Facchini M, Di Martino A, Fabiani C, Lackenby A, Zambon M, Donatelli I.
    Antiviral Res; 2011 Jun 20; 90(3):205-12. PubMed ID: 21514326
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.
    Tulip WR, Varghese JN, Baker AT, van Donkelaar A, Laver WG, Webster RG, Colman PM.
    J Mol Biol; 1991 Sep 20; 221(2):487-97. PubMed ID: 1920429
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Influenza A virus N5 neuraminidase has an extended 150-cavity.
    Wang M, Qi J, Liu Y, Vavricka CJ, Wu Y, Li Q, Gao GF.
    J Virol; 2011 Aug 20; 85(16):8431-5. PubMed ID: 21653672
    [Abstract] [Full Text] [Related]

  • 72. Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk.
    Streltsov VA, Schmidt PM, McKimm-Breschkin JL.
    Acta Crystallogr F Struct Biol Commun; 2019 Feb 01; 75(Pt 2):89-97. PubMed ID: 30713159
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Recent Progress on Computer-Aided Inhibitor Design of H5N1 Influenza A Virus.
    Guo X, Wang JF, Zhu Y, Wei DQ.
    Curr Comput Aided Drug Des; 2010 Feb 01; 6(2):139-46. PubMed ID: 20402663
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble.
    Landon MR, Amaro RE, Baron R, Ngan CH, Ozonoff D, McCammon JA, Vajda S.
    Chem Biol Drug Des; 2008 Feb 01; 71(2):106-16. PubMed ID: 18205727
    [Abstract] [Full Text] [Related]

  • 80. Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations.
    Chachra R, Rizzo RC.
    J Chem Theory Comput; 2008 Sep 09; 4(9):1526-40. PubMed ID: 26621436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.